Company Daan Gene Co., Ltd.

002030

CNE000001KP1

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-04-24 pm EDT			5-day change	1st Jan Change
7.41 ^CNY	+0.27%		-0.54%	-23.45%

Mar. 29	Daan Gene Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Daan Gene Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	CI

Business Summary

Da An Gene Co., Ltd. specializes in the development, manufacture and marketing of molecular diagnosis products for infectious and epidemic diseases. The group offers real-time polymerase chain reaction instruments (QPCR), immunological products, screening systems for cervical cancer, sequencing tools, blood collection tubes and food safety products.

Number of employees: 1,968

Sales per Business

CNY in Million	2022	Weight	2023	Weight	Delta
Biological Products and Related Business 97.1 %	12,010	99.7 %	1,146	97.1 %	-90.46%
Financial 2.9 %	36	0.3 %	35	2.9 %	-3.54%

Sales per region

CNY in Million	2022	Weight	2023	Weight	Delta
China 100.0 %	12,046	100.0 %	1,181	100.0 %	-90.20%

Managers

Managers	Title	Age	Since
Luo Huang CEO	Chief Executive Officer	44	21-05-31
Wei Jie Zhang DFI	Director of Finance/CFO	53	15-03-25
Xi Wen Jiang BRD	Director/Board Member	42	21-06-25
Bin Zhang BRD	Director/Board Member	57	06-04-24
Yu Ting Ceng IRC	Investor Relations Contact	-	-
Yang Wang PRN	Corporate Officer/Principal	38	-

Members of the board

Members of the board	Title	Age	Since
Zheng Fu Zhu BRD	Director/Board Member	60	22-05-26
Zhe Qiang Xue CHM	Chairman	36	22-07-03
Li Qiang Huang BRD	Director/Board Member	57	03-09-30
Bin Zhang BRD	Director/Board Member	57	06-04-24
Ru Hui Huang BRD	Director/Board Member	51	19-04-18
Wan Yu Zhu CHM	Chairman	51	21-03-20
Yun Hai Ji BRD	Director/Board Member	58	22-05-26
Luo Huang CEO	Chief Executive Officer	44	21-05-31
Xi Wen Jiang BRD	Director/Board Member	42	21-06-25

Share class

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	1,403,446,032	921,235,510 ( 65.64 %)	0	65.64 %

Shareholders

Name	Equities	%	Valuation
Guangzhou State-Owned Assets Supervision & Admin. Commission 32.38 %	443,908,904	32.38 %	512 M ¥
Hwabao WP Fund Management Co., Ltd. 1.944 %	26,660,621	1.944 %	31 M ¥
Yun Shao He 1.859 %	25,483,707	1.859 %	29 M ¥
China Investment Corp. (Investment Management) 0.9348 %	12,817,911	0.9348 %	15 M ¥
Guotai Asset Management Co., Ltd. 0.6729 %	9,226,930	0.6729 %	11 M ¥
China Southern Asset Management Co., Ltd. 0.5217 %	7,153,766	0.5217 %	8 M ¥
GF Fund Management Co., Ltd. 0.3341 %	4,580,607	0.3341 %	5 M ¥
UBS SDIC Fund Management Co., Ltd. 0.2536 %	3,477,323	0.2536 %	4 M ¥
Maxwealth Fund Management Co., Ltd. 0.2376 %	3,258,411	0.2376 %	4 M ¥
Fullgoal Fund Management Co., Ltd. 0.1870 %	2,563,691	0.1870 %	3 M ¥